CN Patent

CN1236813C — 水难溶性药物的自乳化组合物

Assigned to Pharmasolutions Inc · Expires 2006-01-18 · 20y expired

What this patent protects

本发明涉及含有药用有效量亲脂性药物和可药用载体的药物组合物，所述载体含有亲脂性药物增溶有效量的C 6 -C 18 脂肪酸丙二醇酯和非离子表面活性剂，其中所述丙二醇酯含有基于所述丙二醇酯总重至少60%重量的单酯。

USPTO Abstract

本发明涉及含有药用有效量亲脂性药物和可药用载体的药物组合物，所述载体含有亲脂性药物增溶有效量的C 6 -C 18 脂肪酸丙二醇酯和非离子表面活性剂，其中所述丙二醇酯含有基于所述丙二醇酯总重至少60%重量的单酯。

Drugs covered by this patent

Patent Metadata

Patent number
CN1236813C
Jurisdiction
CN
Classification
—
Expires
2006-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Pharmasolutions Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.